Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer

Area of Science:

• Oncology
• Computational Biology
• Pharmacology

Background:

• Breast cancer is a leading cause of death in women globally.
• It is a heterogeneous malignancy with complex molecular mechanisms.
• Identifying new targeted therapies for breast cancer subtypes is crucial.

Purpose of the Study:

• To explore novel drug candidates for breast cancer treatment using computational drug repositioning.
• To identify drugs that can reverse gene expression patterns associated with breast cancer.
• To evaluate the potential of repurposed drugs as combination therapy for breast cancer.

Main Methods:

• Utilized computational drug repositioning and gene expression-based signatures.
• Acquired drug activity and gene expression data from DrugBank, PubChem, and LINCS databases.
• Performed in silico drug screening, molecular dynamics (MD), replica exchange MD, and simulated annealing MD (SAMD) simulations.

Main Results:

• Identified furosemide, gold, and dopamine as compounds with significant therapeutic potential.
• Observed that these drugs reversed the expression of key genes involved in breast cancer.
• Demonstrated the efficacy of these compounds through various in silico simulation techniques.

Conclusions:

• Furosemide, gold, and dopamine show promise as novel therapeutic agents for breast cancer.
• The reversal of gene expression by these drugs supports their potential in breast cancer treatment.
• A combination therapy involving furosemide, gold, and dopamine may offer a new strategy for breast cancer patients.